Litcius/Paper detail

Refining risk stratification in HR-positive/HER2-negative early breast cancer: how to select patients for treatment escalation?

Stefania Morganti, Antonio Marra, Edoardo Crimini, Paolo D’Amico, Paola Zagami, Giuseppe Curigliano

2022Breast Cancer Research and Treatment13 citationsDOI

Topics & Concepts

MedicineOncologyGrading (engineering)Breast cancerLiquid biopsyInternal medicineBiopsyRisk assessmentRisk stratificationPathologicalCancerComputer scienceCivil engineeringComputer securityEngineeringBreast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchAdvanced Breast Cancer Therapies
Refining risk stratification in HR-positive/HER2-negative early breast cancer: how to select patients for treatment escalation? | Litcius